Adherence to lipid-lowering medication in people living with HIV: An outpatient clinic drug direct distribution experience

Objective: Adherence to lipid-lowering drugs could be challenging in our patients as it is in the general population, which is described as low as 25%. Our aim was to evaluate adherence to statins and to investigate clinical event impact on it. Methods: This retrospective study on HIV+ patients atte...

Full description

Bibliographic Details
Main Authors: Gianluca Cuomo, Alessandro Raimondi, Marianna Rivasi, Giovanni Guaraldi, Vanni Borghi, Cristina Mussini
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Journal of Research in Pharmacy Practice
Subjects:
Online Access:http://www.jrpp.net/article.asp?issn=2319-9644;year=2021;volume=10;issue=1;spage=10;epage=16;aulast=Cuomo
_version_ 1819101856716029952
author Gianluca Cuomo
Alessandro Raimondi
Marianna Rivasi
Giovanni Guaraldi
Vanni Borghi
Cristina Mussini
author_facet Gianluca Cuomo
Alessandro Raimondi
Marianna Rivasi
Giovanni Guaraldi
Vanni Borghi
Cristina Mussini
author_sort Gianluca Cuomo
collection DOAJ
description Objective: Adherence to lipid-lowering drugs could be challenging in our patients as it is in the general population, which is described as low as 25%. Our aim was to evaluate adherence to statins and to investigate clinical event impact on it. Methods: This retrospective study on HIV+ patients attending to Clinic of Modena (Italy) was conducted in order to evaluate characteristics, clinical events, and adherence on lipid-lowering drugs. All drugs for comorbidities are distributed by the hospital pharmacy and recorded in an electronical database. Adherence was also evaluated in patients who were supplied with antilipemics in external pharmacies through phone calls. Patients were considered adherent if the percentage of correct time of drug refill was >80%. Findings: Totally 1123 patients were evaluated. Lipid-lowering drugs (statins, fenofibrate, and omega-3 oil) were prescribed in 242 patients (21.5%). Prescription occurred mainly in those who were older, males, and Italians. Two hundred of them (82.6%) used statins alone, 23 (9.5%) only fenofibrate or omega-3 oil, and 19 (7.8%) a combination of both drugs. The median adherence was 90% while patients with adherence >80% resulted 153 (63.2%). Forty-six (19%) had a clinical history of cardiovascular events; 59% of them, placed in secondary prophylaxis, and 76%, already in treatment, continued to adhere. No differences in terms of adherence according to the type of drug distribution (hospital pharmacy or outside pharmacies) were found. Conclusion: Linking the supply of these drugs to that of antiretrovirals led to a good level of adherence higher than that described in the general population. The majority of the patients who experienced a cardiovascular event remain adherent to the prescribed therapy.
first_indexed 2024-12-22T01:25:19Z
format Article
id doaj.art-fa0ec8d2979a430c930b8f251a6bdc4b
institution Directory Open Access Journal
issn 2319-9644
2279-042X
language English
last_indexed 2024-12-22T01:25:19Z
publishDate 2021-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Research in Pharmacy Practice
spelling doaj.art-fa0ec8d2979a430c930b8f251a6bdc4b2022-12-21T18:43:37ZengWolters Kluwer Medknow PublicationsJournal of Research in Pharmacy Practice2319-96442279-042X2021-01-01101101610.4103/jrpp.JRPP_20_96Adherence to lipid-lowering medication in people living with HIV: An outpatient clinic drug direct distribution experienceGianluca CuomoAlessandro RaimondiMarianna RivasiGiovanni GuaraldiVanni BorghiCristina MussiniObjective: Adherence to lipid-lowering drugs could be challenging in our patients as it is in the general population, which is described as low as 25%. Our aim was to evaluate adherence to statins and to investigate clinical event impact on it. Methods: This retrospective study on HIV+ patients attending to Clinic of Modena (Italy) was conducted in order to evaluate characteristics, clinical events, and adherence on lipid-lowering drugs. All drugs for comorbidities are distributed by the hospital pharmacy and recorded in an electronical database. Adherence was also evaluated in patients who were supplied with antilipemics in external pharmacies through phone calls. Patients were considered adherent if the percentage of correct time of drug refill was >80%. Findings: Totally 1123 patients were evaluated. Lipid-lowering drugs (statins, fenofibrate, and omega-3 oil) were prescribed in 242 patients (21.5%). Prescription occurred mainly in those who were older, males, and Italians. Two hundred of them (82.6%) used statins alone, 23 (9.5%) only fenofibrate or omega-3 oil, and 19 (7.8%) a combination of both drugs. The median adherence was 90% while patients with adherence >80% resulted 153 (63.2%). Forty-six (19%) had a clinical history of cardiovascular events; 59% of them, placed in secondary prophylaxis, and 76%, already in treatment, continued to adhere. No differences in terms of adherence according to the type of drug distribution (hospital pharmacy or outside pharmacies) were found. Conclusion: Linking the supply of these drugs to that of antiretrovirals led to a good level of adherence higher than that described in the general population. The majority of the patients who experienced a cardiovascular event remain adherent to the prescribed therapy.http://www.jrpp.net/article.asp?issn=2319-9644;year=2021;volume=10;issue=1;spage=10;epage=16;aulast=Cuomoadherenceantilipemicshivmedicationstatins
spellingShingle Gianluca Cuomo
Alessandro Raimondi
Marianna Rivasi
Giovanni Guaraldi
Vanni Borghi
Cristina Mussini
Adherence to lipid-lowering medication in people living with HIV: An outpatient clinic drug direct distribution experience
Journal of Research in Pharmacy Practice
adherence
antilipemics
hiv
medication
statins
title Adherence to lipid-lowering medication in people living with HIV: An outpatient clinic drug direct distribution experience
title_full Adherence to lipid-lowering medication in people living with HIV: An outpatient clinic drug direct distribution experience
title_fullStr Adherence to lipid-lowering medication in people living with HIV: An outpatient clinic drug direct distribution experience
title_full_unstemmed Adherence to lipid-lowering medication in people living with HIV: An outpatient clinic drug direct distribution experience
title_short Adherence to lipid-lowering medication in people living with HIV: An outpatient clinic drug direct distribution experience
title_sort adherence to lipid lowering medication in people living with hiv an outpatient clinic drug direct distribution experience
topic adherence
antilipemics
hiv
medication
statins
url http://www.jrpp.net/article.asp?issn=2319-9644;year=2021;volume=10;issue=1;spage=10;epage=16;aulast=Cuomo
work_keys_str_mv AT gianlucacuomo adherencetolipidloweringmedicationinpeoplelivingwithhivanoutpatientclinicdrugdirectdistributionexperience
AT alessandroraimondi adherencetolipidloweringmedicationinpeoplelivingwithhivanoutpatientclinicdrugdirectdistributionexperience
AT mariannarivasi adherencetolipidloweringmedicationinpeoplelivingwithhivanoutpatientclinicdrugdirectdistributionexperience
AT giovanniguaraldi adherencetolipidloweringmedicationinpeoplelivingwithhivanoutpatientclinicdrugdirectdistributionexperience
AT vanniborghi adherencetolipidloweringmedicationinpeoplelivingwithhivanoutpatientclinicdrugdirectdistributionexperience
AT cristinamussini adherencetolipidloweringmedicationinpeoplelivingwithhivanoutpatientclinicdrugdirectdistributionexperience